Skip to main content
. 2024 Dec 5;16:1465016. doi: 10.3389/fnagi.2024.1465016

FIGURE 2.

FIGURE 2

Serum NfL levels in PD-CN patients and NC at baseline and follow-up time. NC, normal controls; NfL, neurofilament light chain; PD-CN, cognitively normal Parkinson’s disease. *p < 0.05, **p < 0.01, ***p < 0.001.